Cogentix Medical, Inc.
CGNT
CGNT was delisted on the 20th of April, 2018.
37 hedge funds and large institutions have $20.6M invested in Cogentix Medical, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
53% more capital invested
Capital invested by funds: $13.4M → $20.6M (+$7.13M)
9% more funds holding
Funds holding: 34 → 37 (+3)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$488K |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$329K |
| 3 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$161K |
| 4 |
Renaissance Technologies
New York
|
+$153K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$131K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$198K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$185K |
| 3 |
Millennium Management
New York
|
-$70.8K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$65.7K |
| 5 |
Goldman Sachs
New York
|
-$33K |
CGNT Hedge Fund Activity: Q3 2017 in Review
37 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q3 2017, worth a combined $20.6M — up 53% from $13.4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CGNT positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $488K. The largest seller was Broadfin Capital, cutting an estimated $198K.
- 37 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q3 2017, up from 34 in Q2 2017.
- Funds reported $20.6M of Cogentix Medical, Inc. stock for Q3 2017, up 53% quarter-over-quarter.
- 9 funds opened new Cogentix Medical, Inc. positions in Q3 2017 and 5 closed out, a net change of +4 holders.
- The largest Cogentix Medical, Inc. buyer in Q3 2017 was Vanguard Group, an estimated $488K added.
- The largest Cogentix Medical, Inc. seller in Q3 2017 was Broadfin Capital, an estimated $198K sold.
Based on aggregated 13F filings for Q3 2017.